Tempus AI, Inc.
NASDAQ:TEMMedical - Healthcare Information Services
-$1.77 today
- Market cap
- $11.28B
- Beta
- 3.62
- P/E (TTM)
- -28.8
- EPS (TTM)
- -$1.69
Volume 5.35M
Average 6.17M
TEM Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Tempus AI, Inc.NASDAQ: TEM
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures dips below year-ago levels
Q3 FY2026 capital expenditures of $2.51M (cash outflow) fell 68.9% year over year, behind the +3.8% change in trailing-twelve-month capital expenditures. Sequentially, it fell 77.4% from the prior quarter. Over 3 fiscal years it compounded at +14.1% a year.
Context
- Capital expenditures amounted to 2.1% of revenue in FY2025, down 1.0 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -68.9% toward the trailing-twelve-month pace of +3.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (27.27M) USD
- Year-over-year change
- -23.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (27.27M) | -23.3% |
| FY2024 | 2024-12-31 | (22.12M) | +36.1% |
| FY2023 | 2023-12-31 | (34.61M) | -88.3% |
| FY2022 | 2022-12-31 | (18.38M) | -56.2% |
| FY2021 | 2021-12-31 | (11.77M) | — |
Capital Expenditures vs competitors
How TEM compares with its peers on the latest reported figures
- TEM's LTM Sep 2026 capital expenditures of $30M is the 6th largest of the 11 companies compared; the peer median is $44.04M.
- Its year-over-year change of +3.8% is the 7th highest of 10, against a peer median of +17.1%.
- Capital expenditures amounts to 2.0% of revenue for TEM, versus a peer median of 4.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $576M | +17.1% | +9.3% | 4.9% | |
| LTM Jun 2026 | $206.77M | +15.7% | +10.4% | 9.8% | |
| LTM Jun 2026 | $156.54M | +90.6% | +30.6% | 5.8% | |
| LTM Jun 2026 | $156M | +26.8% | -19.7% | 3.5% | |
| LTM Sep 2026 | $58.67M | +49.2% | -14.6% | 4.6% | |
| LTM Sep 2026 | $30M | +3.8% | +14.1% | 2.0% | |
| LTM Jun 2026 | $29.4M | -11.5% | -4.4% | 3.8% | |
| LTM Mar 2026 | $23.2M | -21.1% | -29.9% | 2.8% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $12.18M | — | — | 3.1% |
| LTM Mar 2026 | $5.19M | +29.3% | -55.1% | 8.0% | |
| LTM Mar 2026 | $411K | -87.6% | -51.5% | 0.4% | |
| Peer median (excluding TEM) | $44.04M | +17.1% | -14.6% | 4.2% | |
Competitors are the stored peer set for TEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (259.19M) | (289.81M) | (214.12M) | (705.81M) | (245.03M) |
| Depreciation & Amortization | 23.88M | 30.41M | 33.33M | 37.25M | 102.32M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (52.67M) |
| Stock-Based Compensation | 559K | 0 | 0 | 534.14M | 124.75M |
| Change in Working Capital | 14.55M | 71.82M | (37.84M) | (37.8M) | (178.55M) |
| Accounts Receivables | 4.75M | (8.2M) | (7.35M) | (61.04M) | (90.4M) |
| Inventory | 14.65M | (1.31M) | (6.56M) | (9.54M) | (3.37M) |
| Accounts Payables | (30.47M) | (7.92M) | (23.36M) | (23.85M) | (7.24M) |
| Other Working Capital | 25.63M | 89.25M | (564K) | 56.63M | (77.54M) |
| Other Non-Cash Items | 8.22M | 19.38M | 4.28M | (16.82M) | 31.08M |
| Operating Cash Flow | (211.98M) | (168.2M) | (214.34M) | (189.05M) | (218.09M) |
| Capital Expenditures | (11.77M) | (18.38M) | (34.61M) | (22.12M) | (27.27M) |
| Acquisitions (Net) | (5.96M) | (39.56M) | (5.71M) | (95.19M) | (376.67M) |
| Purchases of Investments | 0 | 0 | 0 | (36.18M) | (2.74M) |
| Sales of Investments | 0 | 0 | 0 | 23.1M | 8.32M |
| Other Investing Activities | (4M) | 0 | 0 | 0 | (6.22M) |
| Investing Cash Flow | (21.72M) | (57.94M) | (40.31M) | (130.39M) | (398.36M) |
| Debt Repayment | (796K) | 170.25M | 82.59M | 0 | 735.76M |
| Common Stock Issued | 0 | 0 | 0 | 381.95M | 195.5M |
| Common Stock Repurchased | 0 | 0 | (3.6M) | 0 | (3.04M) |
| Dividends Paid | (5.63M) | (5.63M) | (5.63M) | (5.63M) | 0 |
| Other Financing Activities | (4.51M) | (5.43M) | (698K) | (79.5M) | (44.1M) |
| Financing Cash Flow | (2.04M) | 251.39M | 117.55M | 494.33M | 884.12M |
| Effect of Forex Changes | (3K) | 17K | (19K) | 336K | (62K) |
| Net Change in Cash | (235.75M) | 25.27M | (137.12M) | 175.23M | 267.62M |
| Free Cash Flow | (223.75M) | (186.58M) | (248.95M) | (211.17M) | (245.36M) |
Tempus AI, Inc.
NASDAQ:TEM
Intrinsic Alpha fair value
Locked
Current Price
$63.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.